Skip to content

Study on MEG-based analysis of brain oscillation characteristics in patients with temporal lobe epilepsy

Study on MEG-based analysis of brain oscillation characteristics in patients with temporal lobe epilepsy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077069
Enrollment
Unknown
Registered
2023-10-27
Start date
2023-10-27
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporal lobe epilepsy

Interventions

healthy subjects:magnetoencephalography
patients of temporal lobe epilepsy:no intervention

Sponsors

Xuanwu Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 60 Years

Inclusion criteria

Inclusion criteria: The criteria for patients of temporal lobe epilepsy: ? Patients diagnosed with temporal lobe epilepsy after standard preoperative assessment of epilepsy; ? follow-up for 1 year; ? follow-up Enel grade Ia, that is, no postoperative seizures; ? with preoperative magnetic encephalography; ? right-handed; ? gender limitation, 10 years = age = 60 years. The criteria for enrollment of healthy subjects: ? physical health, no neurological disease, or other major systemic diseases; ? normal cognitive function, no mental disorders; ? no metal implants in the body; ? no previous craniocerebral surgery, no major craniocerebral trauma; ? right hand; ?no gender restriction,10 years = age = 60 years.

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients with temporal lobe epilepsy: ? Cranial imaging indicated significant cranioencephalies and intracranial space-occupying lesions; ? with significant structural changes in the brain due to previous head surgery, brain trauma or other causes; ? with a pacemaker, vagus nerve stimulator or other metal implants in the body. Exclusion criteria for healthy subjects: ? alcohol abuse or substance dependence; ? those who took benzodiazepine within 1 month prior to the trial; ? pregnant women; ? subjects at any stage of the study; ? who cannot cooperate with MEG examinations; ? subjects with acute fever and other vital signs during MEG; ? Other conditions who were found not to meet the protocol after enrollment.

Design outcomes

Primary

MeasureTime frame
Cross frequency coupling;Phase Locking Value;

Countries

China

Contacts

Public ContactYicong Lin

Xuanwu Hospital, Capital Medical University

Linyc_1@163.com+86 136 7108 6598

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026